Device Trial Radar · NCT03516136
Safety and Performance of the EndoFast Reliant SCP in Vaginal Wall Reinforcement
Last checked: Nov 20, 2026Latest source record: May 17, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
84
Actual
Start
Jan 1, 2015
Primary completion
Dec 31, 2017
Study completion Dec 31, 2017
Sponsor
- Lead sponsor
- Allium, Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 4, 2018
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Single arm, single site, retrospective cohort Post Marketing Clinical Follow up Study Evaluating the Safety and Performance of the EndoFast Reliant SCP for apical support.
Conditions
- Pelvic Organ Prolapse
Interventions
EndoFast Reliant SCPDevice
POP repair procedure with the EndoFast Reliant SCP system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety- procedure and device related complication rateTime frame: Up to 4 years
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.